NCT00017498View on ClinicalTrials.gov

Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

April 30, 2003

Conditions
Head and Neck Cancer
Interventions
DRUG

gemcitabine hydrochloride

Trial Locations (7)

1000

Institut Jules Bordet, Brussels

12100

Ospedale Santa Croce, Cuneo

20133

Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-3000

U.Z. Gasthuisberg, Leuven

1007 MB

Vrije Universiteit Medisch Centrum, Amsterdam

NL-6500 HB

University Medical Center Nijmegen, Nijmegen

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00017498 - Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck | Biotech Hunter | Biotech Hunter